Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
150.40B
Market cap150.40B
Price-Earnings ratio
19.40
Price-Earnings ratio19.40
Dividend yield
6.54%
Dividend yield6.54%
Average volume
39.99M
Average volume39.99M
High today
$26.95
High today$26.95
Low today
$26.01
Low today$26.01
Open price
$26.58
Open price$26.58
Volume
57.66M
Volume57.66M
52 Week high
$28.75
52 Week high$28.75
52 Week low
$21.97
52 Week low$21.97

Stock Snapshot

The current Pfizer(PFE) stock price is $26.50, with a market capitalization of 150.4B. The stock trades at a price-to-earnings (P/E) ratio of 19.40 and offers a dividend yield of 6.5%.

On 2026-05-06, Pfizer(PFE) stock traded between a low of $26.01 and a high of $26.95. Shares are currently priced at $26.50, which is +1.9% above the low and -1.7% below the high.

The Pfizer(PFE)'s current trading volume is 57.66M, compared to an average daily volume of 39.99M.

In the last year, Pfizer(PFE) shares hit a 52-week high of $28.75 and a 52-week low of $21.97.

In the last year, Pfizer(PFE) shares hit a 52-week high of $28.75 and a 52-week low of $21.97.

PFE News

TipRanks 4h
Pfizer Earnings Call Highlights Growth Beyond COVID

Pfizer Inc ((PFE)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and powerful...

Simply Wall St 6h
Pfizer’s First PROTAC Approval Adds New Dimension To Oncology Story

FDA approves VEPPANU (vepdegestrant), co developed by Arvinas and Pfizer, as the first PROTAC protein degrader therapy for advanced ER+/HER2, ESR1 mutated breas...

Pfizer’s First PROTAC Approval Adds New Dimension To Oncology Story
TipRanks 8h
Pfizer sees high-single-digit annual revenue increases 2029-2033, WSJ reports

Pfizer (PFE) expects to return to consistent growth by 2029, targeting high-single-digit annual revenue increases through 2033, supported by a predictable post-...

Analyst ratings

50%

of 30 ratings
Buy
40%
Hold
50%
Sell
10%

More PFE News

Nasdaq 9h
Pfizer Q1 2026 Earnings Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

Pfizer Q1 2026 Earnings Transcript
Benzinga 12h
Pfizer Says Vyndamax Drug Patent Settlement Reshapes Post-2028 Revenue View

This positive momentum comes alongside a broader market environment where S&P 500 futures are gaining by 0.4%, suggesting a favorable tone for equities overall....

Pfizer Says Vyndamax Drug Patent Settlement Reshapes Post-2028 Revenue View
Sherwood News 16h
Pfizer reports Q1 results above consensus, reaffirms 2026 guidance

Pfizer reports Q1 results above consensus, reaffirms 2026 guidance Pfizer rose in premarket trading after it reported earnings results that beat Wall Street ex...

Pfizer reports Q1 results above consensus, reaffirms 2026 guidance
TipRanks 17h
PFE Earnings: Pfizer Stock Rises on Q1 Beat despite Lower 2026 Sales Outlook

Pfizer’s (PFE) shares rose over 2% early Tuesday after the American pharma giant released first-quarter 2026 earnings results that surpassed the Wall Street con...

The Wall Street Journal 17h
Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

First-quarter revenue rose 5% to $14.45 billion. Wall Street expected $13.84 billion. clodagh kilcoyne / Reuters Pfizer PFE -0.11 %decrease; red down pointing...

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending
CNBC 17h
Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. Pfizer on Tuesday posted first-quarter earnings and revenue that topped...

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth
Nasdaq 18h
Pfizer Q1 26 Earnings Conference Call At 10:00 AM ET

(RTTNews) - Pfizer Inc. (PFE) will host a conference call at 10:00 AM ET on Tuesday, May 5, 2026 ,to discuss Q1 26 earnings results. To access the live webcast...

Pfizer Q1 26 Earnings Conference Call At 10:00 AM ET

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.